ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,758,469 | -0.4% | 12,781,695 | +2.7% | 0.00% | 0.0% |
Q2 2023 | $45,923,913 | +17.5% | 12,445,505 | +5.4% | 0.00% | 0.0% |
Q1 2023 | $39,096,486 | -7.4% | 11,811,627 | +8.6% | 0.00% | 0.0% |
Q4 2022 | $42,209,197 | +87.0% | 10,878,659 | +17.1% | 0.00% | 0.0% |
Q3 2022 | $22,576,000 | +26.1% | 9,290,699 | +2.8% | 0.00% | 0.0% |
Q2 2022 | $17,899,000 | +20.2% | 9,040,244 | +11.1% | 0.00% | – |
Q1 2022 | $14,893,000 | +24.5% | 8,138,420 | -4.1% | 0.00% | – |
Q4 2021 | $11,963,000 | +85.0% | 8,484,060 | +48.2% | 0.00% | – |
Q3 2021 | $6,467,000 | -27.9% | 5,723,351 | +2.0% | 0.00% | – |
Q2 2021 | $8,975,000 | +23.0% | 5,609,220 | +35.3% | 0.00% | – |
Q1 2021 | $7,297,000 | -5.8% | 4,146,115 | +4.4% | 0.00% | – |
Q4 2020 | $7,743,000 | -11.0% | 3,971,343 | +9.1% | 0.00% | – |
Q3 2020 | $8,702,000 | -15.5% | 3,640,735 | +3.6% | 0.00% | – |
Q2 2020 | $10,293,000 | +0.4% | 3,512,918 | -1.3% | 0.00% | – |
Q1 2020 | $10,253,000 | +10.8% | 3,560,386 | +54.0% | 0.00% | – |
Q4 2019 | $9,250,000 | -5.1% | 2,312,539 | +5.6% | 0.00% | – |
Q3 2019 | $9,746,000 | +2.9% | 2,190,044 | -10.5% | 0.00% | – |
Q2 2019 | $9,474,000 | +50.4% | 2,448,253 | +47.3% | 0.00% | – |
Q1 2019 | $6,298,000 | +98.8% | 1,661,686 | +25.4% | 0.00% | – |
Q4 2018 | $3,168,000 | -57.2% | 1,325,277 | +11.1% | 0.00% | – |
Q3 2018 | $7,406,000 | +44.8% | 1,192,641 | +5.2% | 0.00% | – |
Q2 2018 | $5,115,000 | +25.4% | 1,134,031 | +27.9% | 0.00% | – |
Q1 2018 | $4,080,000 | +98.7% | 886,987 | +38.7% | 0.00% | – |
Q4 2017 | $2,053,000 | +113.9% | 639,506 | +105.3% | 0.00% | – |
Q3 2017 | $960,000 | +66.7% | 311,514 | +107.6% | 0.00% | – |
Q2 2017 | $576,000 | -21.3% | 150,028 | 0.0% | 0.00% | – |
Q1 2017 | $732,000 | -1.6% | 150,028 | +3.2% | 0.00% | – |
Q4 2016 | $744,000 | -24.8% | 145,394 | +6.5% | 0.00% | – |
Q3 2016 | $990,000 | +37.5% | 136,537 | +12.9% | 0.00% | – |
Q2 2016 | $720,000 | -25.8% | 120,959 | +0.8% | 0.00% | – |
Q1 2016 | $971,000 | +353.7% | 119,959 | +354.2% | 0.00% | – |
Q4 2015 | $214,000 | -99.8% | 26,411 | -98.9% | 0.00% | -100.0% |
Q3 2015 | $94,155,000 | +73458.6% | 2,384,633 | +17217.6% | 0.00% | – |
Q2 2015 | $128,000 | – | 13,770 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |